DUBLIN--(BUSINESS WIRE)--Aug 29, 2018--The "Global Blood Stream Infection Testing Market Analysis 2017 - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Annual estimations and forecasts are provided from the year 2014 to 2025 for each given segment and sub segments. The report analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

Key Topics Covered

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porter's Five Force Analysis

5 Blood Stream Infection Testing Market by Test Type

6 Blood Stream Infection Testing Market by Technology

7 Blood Stream Infection Testing Market by Product

8 Blood Stream Infection Testing Market by Application

9 Blood Stream Infection Testing Market by End User

10 Geographical Segmentation

11 Vendor Landscaping

12 Company Profiles

Cepheid Thermo Fisher Scientific Biomerieux Inc. Siemens Healthcare Becton, Dickinson and Company Alere Inc. Abbott Laboratories C. R. Bard Inc. Beckman Coulter Inc. F. Hoffmann-LA Roche AG

For more information about this report visit https://www.researchandmarkets.com/research/xc67sr/global_blood?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180829005439/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Disease Testing

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY INFECTIOUS DISEASES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/29/2018 09:36 AM/DISC: 08/29/2018 09:36 AM

http://www.businesswire.com/news/home/20180829005439/en